# AquiSense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aquisense

- Industry: Consumer Products
- Headquarters: Erlanger, US
- Website: www.aquisense.com
- Total disclosed funding: $2.5M
- Latest round: Series A (Mar 28, 2025)
- Investors on record: 2

## About

AquiSense Inc. is a leading innovator in UV-C LED disinfection technology, focusing on solutions for effective sanitation of water, air, and surfaces across various sectors.AquiSense Inc. is specialized in UV-C LED disinfection systems. The company was founded in 2015 by Oliver Lawal and CTO Jennifer Pagán in Erlanger, US. In March 2025, AquiSense Inc. raised USD 2.5 million in Series A funding led by Burnt Island Ventures, with participation from Kentucky Seed Capital Fund. AquiSense Inc. specializes in the design and manufacture of UV-C LED disinfection systems aimed at addressing critical challenges in water, air, and surface sanitation. Their core product offerings include the PearlAqua range, which consists of compact systems tailored for water disinfection, and various surface and air treatment solutions utilizing advanced UV-C LED technology. The products are utilized in residential, commercial, and municipal sectors, providing effective disinfection to a diverse clientele, including households, healthcare facilities, transportation systems, and industrial applications. AquiSense's innovative technologies have been piloted in various geographical markets, including Europe, North America, and parts of Asia, with notable implementations in drinking water treatment plants and wastewater management systems. The company’s unique approach to integrating patented technology and high-quality LED devices ensures reliable and efficient disinfection solutions that cater to users ranging from private homeowners to large-scale municipal utilities.AquiSense Inc. generates revenue primarily through direct sales of its disinfection systems and partnerships with distributors and service providers across various industries. The transactional structure involves B2B sales where clients purchase products directly for installation in facilities such as hospitals, water treatment plants, and commercial establishments. Flagship products, such as the PearlAqua Micro and PearlLab series, are central to their offerings, securing contracts with municipalities and industrial clients looking for effective disinfection solutions. Revenue is structured around one-time purchases, with potential ongoing maintenance or service agreements as part of the client relationship, enhancing customer loyalty and operational efficiency. The company’s focus on delivering innovative, mercury-free disinfection solutions aligns with its commitment to protecting public health and supporting global sustainability efforts. In March 2025, AquiSense Inc. raised USD 2.5 millon in Series A funding to support its expansion into new water treatment sectors, including beverage, pharmaceutical, oil and gas, and municipal applications. The funding will facilitate the development of upcoming products aimed at enhancing their disinfection technology and entering new geographic markets to serve a broader clientele.

## Funding rounds

- Series A, Mar 28, 2025, $2.5M — Kentucky Seed Capital Fund, Burnt Island Ventures

## Investors

- Kentucky Seed Capital Fund (https://capitalatlas.ai/funds/kentucky-seed-capital-fund) — Series A
- Burnt Island Ventures (https://capitalatlas.ai/funds/burnt-island-ventures) — Series A